Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Cacaito who wrote (14728)	9/18/2000 1:18:42 PM
From: aknahow	Respond to of 17367

Cacaito my problem was more with your reasoning. 1. Clinacal trial subjects must give consent. 6 hr. delay tough. Deal with it. 2. Bad things happen when Nazi like expermination is done without consent. 3. But o.k. to get oral consent and then institutional consent in countries where documentation of the oral consent by recording what they were told and their response probably is not done. That is what I had problems with. I fully understand that if institutional consent works and is used in the third world that a 6 hour enrollement processs is probably not needed for something like Meningococcemia. Institutional consent would work well but your friends in the FDA would never, ever accept it. I would like to know how many parents turned down participation in the Meningococcemia trial, for other than religious reasons. If parents did not reject participation because they felt participation would hurt their child then seeking consent could be continued but if no one cared and just wanted treatment, why in the world are companies forced to go thru the red tape for drugs that are safe, (the relative nature of this word is understood).